COMPANY

Anvion Bio, Inc.

Anvion Bio manufactures hydroxylapatite chromatography media used for purification in biomanufacturing. Source · checked Oct 14, 2026

Keywords: CDMO chromatography media hydroxylapatite purification biomanufacturing San Diego

Location: San Diego, CA · source · Oct 14, 2026

Profile checked Oct 14, 2026

Sourced facts

SEC Form D raise Raised $100K (Form D filed Oct 7, 2026). SEC Form D 0001493152-26-046112 (Oct 7, 2026)
Evidence (1 event)
- Oct 7, 2026 · SEC Form D 0001493152-26-046112
  Name of Issuer: Anvion Bio, Inc.; CIK: 2158000; Address: San Diego, CA; Submission type: D; Filing date: 2026-10-07; Industry Group: Pharmaceuticals; Date of First Sale: 2026-09-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 100000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals